IRIS UniCatt

Napolitano, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.243
AS - Asia 1.168
EU - Europa 797
SA - Sud America 316
AF - Africa 36
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.179
SG - Singapore 512
IT - Italia 284
BR - Brasile 253
CN - Cina 240
VN - Vietnam 166
FR - Francia 104
DE - Germania 93
SE - Svezia 87
GB - Regno Unito 44
FI - Finlandia 43
JP - Giappone 40
CA - Canada 37
BD - Bangladesh 34
KR - Corea 29
ID - Indonesia 27
IE - Irlanda 25
IN - India 25
HK - Hong Kong 23
AR - Argentina 22
IQ - Iraq 20
RU - Federazione Russa 18
NL - Olanda 17
ES - Italia 15
ZA - Sudafrica 15
MX - Messico 14
PL - Polonia 14
TR - Turchia 12
CO - Colombia 11
EC - Ecuador 11
AT - Austria 10
IL - Israele 7
SA - Arabia Saudita 6
SI - Slovenia 6
UA - Ucraina 6
LT - Lituania 5
MA - Marocco 5
CH - Svizzera 4
PR - Porto Rico 4
PT - Portogallo 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
DZ - Algeria 2
LV - Lettonia 2
LY - Libia 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
SV - El Salvador 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KW - Kuwait 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.563
Salva come PNG Salva come JPEG
Città #
Singapore 311
San Jose 184
Ashburn 169
Rome 74
Chandler 70
New York 62
Beijing 56
Ho Chi Minh City 54
Los Angeles 54
The Dalles 51
Hefei 50
Hanoi 48
Tokyo 37
Munich 31
Frankfurt am Main 30
Milan 30
Lauterbourg 29
Seoul 28
São Paulo 26
Dublin 23
Helsinki 23
Hong Kong 22
Jakarta 21
Kent 16
Montreal 16
Boardman 15
Council Bluffs 15
Dallas 14
Marseille 13
Turku 13
Houston 12
North Bergen 12
Paris 12
Boston 11
Brooklyn 11
Poplar 11
Denver 9
Moscow 9
Nuremberg 9
Phoenix 9
Toronto 9
Warsaw 9
Belo Horizonte 8
Da Nang 8
Johannesburg 8
Memphis 8
St Louis 8
Baghdad 7
Bogotá 7
Chicago 7
Mexico City 7
Najaf 7
Orem 7
Princeton 7
Stockholm 7
Atlanta 6
Buffalo 6
Can Tho 6
Falkenstein 6
Guarulhos 6
Lappeenranta 6
Macerata 6
Porto Alegre 6
Rio de Janeiro 6
Santa Clara 6
Seattle 6
Amsterdam 5
Bologna 5
Cagliari 5
Caxias do Sul 5
Hyderabad 5
Mumbai 5
Palermo 5
Tel Aviv 5
Appignano 4
Brasília 4
Bremen 4
Dhaka 4
Düsseldorf 4
Hải Dương 4
Manaus 4
Newark 4
Pune 4
Quito 4
Roubaix 4
Salvador 4
Scandicci 4
Thái Nguyên 4
Trieste 4
Zurich 4
Amman 3
Baku 3
Biên Hòa 3
Buenos Aires 3
Bắc Ninh 3
Calgary 3
Cape Town 3
Catania 3
Charlotte 3
Chelsea 3
Totale 2.004
Salva come PNG Salva come JPEG
Nome #
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 159
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 150
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study 148
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic 146
Addressing Nutritional Knowledge Gaps in Inflammatory Bowel Disease: A Scoping Review 131
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 130
Novel Insights into the Pathogenesis of Inflammatory Bowel Diseases 125
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 125
Validity and Reliability of the Self-Care of Chronic Illness Inventory in Patients Living With Inflammatory Bowel Disease 122
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 122
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 122
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 119
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre 115
Self-care in patients affected by inflammatory bowel disease and caregiver contribution to self-care (IBD-SELF): a protocol for a longitudinal observational study 115
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 113
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 111
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 108
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study 107
Knowledge of perianal Crohn's disease among nurses in an Italian tertiary centre 106
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 102
Patient satisfaction with nursing care during biological therapy for inflammatory bowel disease: An observational study 96
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study 93
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 90
Evaluation of factors associated with trust in telemedicine in patients with inflammatory bowel disease during COVID-19 pandemic: a multicenter cross-sectional survey 87
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 86
Nonmedical switch of anti-TNF-α biosimilars has no major clinical, pharmacokinetic and psychological impact on patients with IBD - the SAFER Study 85
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 79
The inflammatory bowel disease care manager: Italian state of the art 74
Psychological Assessment and Psychosocial Outcomes in Bariatric Surgery Candidates: A Retrospective Study 73
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 72
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus 71
The role of resilience in mitigating depression and anxiety in patients with inflammatory bowel diseases 49
Exploring the Mediating Role of Self-Efficacy in the Relationship Between Caregiver Contribution and Resilience in Inflammatory Bowel Disease 46
Patient Satisfaction with IBD Undergoing Colonoscopy: A Multicenter Cross-Sectional Study 34
The roles and professional competencies of clinical study coordinators and data managers in clinical trials: A systematic review 19
DISYNCRO: Perceived roles of clinical study coordinators and data managers: results from a web-based survey of professionals from contract research organizations 19
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory study 16
Self-Efficacy as a Mediator Between Medication Adherence and Self-Care in Inflammatory Bowel Disease: A Multicenter Cross-Sectional Study 10
Adverse Childhood Experiences and Disease Activity Are Associated with Post-Traumatic Stress Symptoms in Crohn’s Disease 10
Italian version of the General Medication Adherence Scale (GMAS): translation, adaptation, and validation 7
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study 6
Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context 5
Optimizing healthcare through alignment and nurturing across cultures (OHANA) 5
Monitoring the psychopathological profile of inflammatory bowel disease patients treated with biological agents: a pilot study 5
Validity and Reliability of the Caregiver Contribution to Self-Care of Chronic Illness Inventory in Patients With Inflammatory Bowel Disease 4
Meaning, Identity, and Practice in Nipple-Areola Complex Tattooing Among Breast Cancer Survivors: A Scoping Review With a Data Mining Approach 4
Knowledge of perianal Crohn's disease among nurses in an Italian tertiary centre 4
The Body as a Battlefield: Identity Development and Psychosomatic Expression in Eating Disorders Across Childhood and Adolescence 3
Timing of biologic prophylaxis and postoperative recurrence in Crohn's disease: A real-life cohort study using propensity score weighting 2
Totale 3.630
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.874
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202258 1 0 0 2 1 0 0 3 0 18 16 17
2022/2023222 36 28 10 32 18 14 22 7 18 6 15 16
2023/2024251 6 40 16 19 11 35 21 7 17 21 24 34
2024/2025771 8 11 63 22 41 24 59 24 87 88 178 166
2025/20262.225 251 160 158 308 328 115 305 114 128 150 95 113
2026/2027100 100 0 0 0 0 0 0 0 0 0 0 0
Totale 3.630